Feminai is an Israeli healthcare startup based in Tel Aviv that develops breast cancer screening solutions. The company offers a wearable, disposable self-examination patch that combines multi-parameter sensing with artificial intelligence for early breast cancer detection.
Subscribe to see Feminai’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Feminai is a diagnostic equipment company headquartered in Israel. Its most recent funding round, Seed, raised $6M in January 2026. Xcout tracks 6 named people at Feminai, including Michel Assenheimer (Chief Scientific Advisor).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $6M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Feminai's closest competitors — see the full list of competitors and alternatives →
BMTfemme, formerly known as MobileODT, is a health technology company focused on commercializing specialized medical devices and diagnostic solutions. Their portfolio includes point-of-care screening products such as rapid diagnostic tests and mobile health technologies. The company aims to improve accessibility and diagnostic accuracy in clinical settings.
OCON Therapeutics is a medical device company founded in 2011 and headquartered in Modiin, Israel, dedicated to creating new standards of care for women's health.
HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
MetriTrack Inc., founded in 2014 and headquartered in Hillside, Illinois, specializes in advanced breast cancer diagnostic technology, including building 3D visualization for handheld breast ultrasound.
Ottai provides a continuous glucose monitoring system and companion app designed for 24/7 glucose tracking. The company serves individuals managing diabetes by offering wearable devices and AI-powered insights to help monitor glucose fluctuations and build healthier habits without the need for finger pricks.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.